| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| FANGZHOU Aktie jetzt für 0€ handeln | |||||
| 03.09. | Fangzhou Inc.: Fangzhou's AI-Powered Chronic Care Model Named to Fortune China's Best Designs 2026 | 1 | GlobeNewswire (USA) | ||
| 28.08. | Fangzhou Inc. H1 Sales Increase | 3 | RTTNews | ||
| 27.08. | Fangzhou Inc.: Fangzhou Reports Sustained Revenue and Profit Growth as AI-Powered Chronic Care Strategy Gains Momentum | 242 | GlobeNewswire (Europe) | HONG KONG, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, announced its interim results... ► Artikel lesen | |
| 27.08. | FANGZHOU JIANKE (06086): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 2 | HKEx | ||
| 17.08. | FANGZHOU JIANKE (06086): DATE OF BOARD MEETING | 2 | HKEx | ||
| 21.07. | EQS Newswire: Wuhan Queqi Culture Media: 'Grandpa Sugar Pill' Honored at UNESCO Headquarters Centenary Commemoration of Gu Fangzhou Held in France | 707 | EQS Group (EN) | EQS Newswire / 21/07/2026 / 10:22 UTC+8
On July 16, the launch ceremony of the event themed A Century of Legacy, A Future of Shared Prosperity - Commemorative Event for the 100th Anniversary of... ► Artikel lesen | |
| 20.07. | Start von Novo Nordis Medikament treibt Fangzhou Aktie an | 53 | Investing.com Deutsch | ||
| 20.07. | Fangzhou Inc.: Fangzhou Launches Novo Nordisk's Once-Weekly Basal Insulin/GLP-1 Therapy in China | 2.176 | GlobeNewswire (Europe) | SHANGHAI, July 20, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, announced the launch of Kyinsu®... ► Artikel lesen | |
| 09.07. | Fangzhou Inc.: Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care | 2 | GlobeNewswire (USA) | ||
| 17.06. | FANGZHOU JIANKE (06086): AMENDED AND RESTATED ARTICLES OF ASSOCIATION | - | HKEx | ||
| 17.06. | FANGZHOU JIANKE (06086): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 17.06. | FANGZHOU JIANKE (06086): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, JUNE 16, 2026 | 2 | HKEx | ||
| 22.05. | FANGZHOU JIANKE (06086): INVITATION LETTER TO REGISTERED SHAREHOLDERS FOR ONLINE ATTENDANCE AT 2026 ANNUAL GENERAL MEETING | - | HKEx | ||
| 22.05. | FANGZHOU JIANKE (06086): INVITATION LETTER TO NON-REGISTERED HOLDERS FOR ONLINE ATTENDANCE AT 2026 ANNUAL GENERAL MEETING | - | HKEx | ||
| 22.05. | FANGZHOU JIANKE (06086): FORM OF PROXY ANNUAL GENERAL MEETING TO BE HELD ON JUNE 16, 2026 OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF | - | HKEx | ||
| 22.05. | FANGZHOU JIANKE (06086): PROPOSALS FOR GENERAL MANDATE TO ISSUE SHARES AND REPURCHASE MANDATE TO REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS ... | - | HKEx | ||
| 22.05. | FANGZHOU JIANKE (06086): NOTICE OF ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 22.05. | FANGZHOU JIANKE (06086): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION | 1 | HKEx | ||
| 19.05. | Fangzhou Inc.: Fangzhou Ranked among 2025 Guangzhou AI Innovation "Most Promising Enterprises" for AI-Powered Chronic Disease Services | 1 | GlobeNewswire (USA) | ||
| 14.05. | Fangzhou und Tenry Pharmaceutical kooperieren bei KI-gestütztem Diabetes-Management | 1 | Investing.com Deutsch |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 10,400 | +0,29 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| GENEDX | 94,64 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| PROCEPT BIOROBOTICS | 19,300 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| FRESENIUS | 45,895 | +1,11 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | 0,00 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now | ||
| HEARTFLOW | 48,280 | -0,10 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,065 | +0,04 % | LifeStance Health auf Morgan Stanley Konferenz: Wachstum und Margen im Fokus | ||
| AVEANNA HEALTHCARE | 14,325 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,650 | -0,33 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen wegen des... ► Artikel lesen | |
| BETA BIONICS | 19,260 | +0,16 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| TENON MEDICAL | 5,030 | -0,59 % | Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 14, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| BILLIONTOONE | 104,19 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,510 | -0,93 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| ADAPTHEALTH | 5,845 | 0,00 % | Truist reiterates Buy on AdaptHealth stock after CFO change | ||
| KESTRA MEDICAL TECHNOLOGIES | 25,185 | +0,02 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen |